Vanderbilt Heart and Vascular Institute is now offering a new procedure that reduces stroke risk for many high-risk patients during interventions for extracranial carotid disease
A new imaging method makes it possible to directly measure cell division and changes in metabolism in atherosclerotic plaques.
Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease.
When atherosclerosis develops in the coronary arteries over a period of time, complete blockage of that artery can result in chest pain, shortness of breath and decreased quality of life.
A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression.
Vanderbilt researchers have discovered a new target for the prevention of atherosclerotic plaque development and cardiovascular disease.
Accessibility Tools